Accueil   Diary - News   All news ImmunID : Data Advancing for ImmunTraCkeR®

ImmunID : Data Advancing for ImmunTraCkeR®

ImmunID announced that an abstract has been accepted for oral presentation at the Society for Immunotherapy of Cancer Annual Meeting being held November 6 to 9, 2014 in National Harbor, MD. The abstract titled “T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma” will be presented Saturday, November 8, at 5:10 pm during the Session “High Throughput Technologies: Determinants of the Immune Response to Cancer” by Dr. Michael Postow, a medical oncologist in the Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center and lead author on the study. In addition, a poster (#156) will be presented during the annual meeting poster sessions.

Read the press release


ImmunID : diagnostic moléculaire immunitaire